Showing results (51-60 of 396) with videos related to
Sort By:
Pageof 40
Pathology, Research and Practice|March 1, 1983
A contribution to the morphology and pathogenesis of thyroid-like lesions in the kidneyH G Laberke, T Klingebiel, G QuackAmino Acids|October 12, 2000
NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterizationW Danysz, C G Parsons, G QuackJournal of Neural Transmission (Vienna, Austria : 1996)|February 3, 1999
Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in ratsM Karcz-Kubicha, G Quack, W DanyszHormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 5, 2010
Familial hyperaldosteronism I-IIII Quack, O Vonend, L C RumpNeuropharmacology|August 28, 1999
Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical dataC G Parsons, W Danysz, G QuackClinical Genetics|June 1, 1976
Partial deletions and trisomies of chromosome 13; mapping of bands associated with particular malformationsB Noel, B Quack, M O RethoreDeutsches Arzteblatt International|February 4, 2020
Vitamin Substitution Beyond Childhood—Requirements and RisksAlexandra Jungert, Katharina Quack Lötscher, Sabine RohrmannMMW Fortschritte Der Medizin|December 12, 2007
[Therapy-resistant hypertension--the value of aldosterone antagonists]I Quack, M Reincke, L C RumpThe Journal of Physical Chemistry. A|May 15, 2013
Nuclear spin symmetry conservation and relaxation in water ((1)H2(16)O) studied by cavity ring-down (CRD) spectroscopy of supersonic jetsCarine Manca Tanner, Martin Quack, David SchmidigerAmino Acids|October 12, 2000
Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisationC G Parsons, W Danysz, G QuackPageof 40